Objective : To describe the effects of an auditory startle stimulus on bloo
d pressure (BP) and heart rate (HR) in man. Three sound levels were tested.
Design and methods : Twelve normotensive volunteers were studied in supine
position. Polygraphic recordings were obtained for finger BP, R-R interval
using an electrocardiograph, respiratory movements using a thoracoabdominal
belt and for electrooculomyogram using adhesive electrodes, A background n
oise of 55 dB was administered through headphones and the acoustic startle
was generated using 3 synthetized white noises of 95, 110 or 120 dB adminis
tered at 5-min intervals during the teleexpiratory phase in a randomized or
der. Noise duration was fixed to 150 msec. The sham stimulation (0 dB, even
t marker) was compared to the 3 levels of noise lane way ANOVA with repeate
d measures followed by multiple comparisons). Confidence intervals (95%) we
re calculated for BP and HR using the 30 sec period preceding each stimulat
ion to obtain individual significance of the responses for the 30 sec follo
wing each stimulation.
Results : A biphasic cardiovascular profile was observed following noise st
imulation. The early response (0-10 sec) observed after the immediate motor
contraction (blink) combined BP and HR increases. The average systolic BP
rise was 15.9 +/- 2.6 mmHg (peak at 4.8 sec) and the average HR increase wa
s 11.9+/-1.6 bpm (peak at 2.8 sec) for the 110 dB noise. These effects were
highly significant compared to the sham response (P<0.001). This 110 dB in
tensity determined 44% of significant systolic BP values and 25% significan
t HR values during this early period, Similar profiles were obtained with 9
5 and 120 dB with a lesser amplitude. The delayed response (10-30 sec) comb
ined moderate BP and HR decreases.
Conclusion : This is the first description of the BP response to an acute l
oud noise in man. The early (within 10 sec) BP and HR rises may depend upon
the autonomic component of the startle reflex. The reproducibility of this
cardiovascular profile obtained with a 110 dB white noise makes this test
applicable to the clinical trials of antihypertensive drugs.